GSH-1 inhibitors, also known as glutathione synthesis inhibitors, are a class of compounds that target the biosynthesis pathway of glutathione (GSH), a critical antioxidant in cells. Glutathione is synthesized through a two-step enzymatic process, with the first rate-limiting enzyme being glutamate-cysteine ligase (GCL), also referred to as GSH-1. By inhibiting GSH-1, these inhibitors effectively reduce the cellular levels of glutathione, thereby modulating the cellular redox state and the balance of oxidative stress. The reduction of GSH levels impacts a wide range of cellular processes, given that glutathione plays a key role in detoxification, protein folding, and the maintenance of redox-sensitive signaling pathways. GSH-1 inhibitors vary in their chemical structure but often share certain pharmacophores that facilitate the binding to GCL, either through covalent interactions or competitive inhibition at the enzyme's active site. These molecules can be structurally diverse, including small organic compounds, peptides, and other analogs designed to mimic the natural substrates or intermediates of the GSH biosynthetic pathway.
The modulation of GSH levels via GSH-1 inhibition can influence cellular defense mechanisms against oxidative damage and reactive oxygen species (ROS) accumulation. In cellular biochemistry, GSH serves as a primary reducing agent and a cofactor for various enzymes, notably glutathione peroxidases, which detoxify peroxides. By inhibiting GSH-1 and subsequently reducing GSH availability, these inhibitors disrupt the normal scavenging of free radicals and ROS, thus altering the redox equilibrium within the cell. This can lead to shifts in cellular processes such as signal transduction, gene expression, and apoptotic pathways. Furthermore, the effects of GSH-1 inhibitors can be highly cell-type specific, as the dependency on glutathione for cellular function and survival varies greatly across different cell types and physiological contexts. Researchers often explore these compounds to understand fundamental cellular processes related to oxidative stress, redox biology, and the regulation of metabolic pathways that are dependent on glutathione homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
L-Buthionine sulfoximine | 83730-53-4 | sc-200824 sc-200824A sc-200824B sc-200824C | 500 mg 1 g 5 g 10 g | $286.00 $442.00 $1532.00 $2975.00 | 26 | |
A stereo-specific version of BSO that inhibits the same enzyme, potentially having a similar effect on GSH-1. | ||||||
Acivicin | 42228-92-2 | sc-200498B sc-200498C sc-200498 sc-200498D | 1 mg 5 mg 10 mg 25 mg | $104.00 $416.00 $655.00 $1301.00 | 10 | |
An inhibitor of gamma-glutamyl transpeptidase, which could reduce glutathione turnover, thereby influencing GSH-1-related pathways. | ||||||
Ethacrynic acid | 58-54-8 | sc-257424 sc-257424A | 1 g 5 g | $90.00 $300.00 | 5 | |
A diuretic that can conjugate with glutathione, potentially depleting its levels and affecting GSH-1 activity. | ||||||
Sulfasalazine | 599-79-1 | sc-204312 sc-204312A sc-204312B sc-204312C | 1 g 2.5 g 5 g 10 g | $61.00 $77.00 $128.00 $209.00 | 8 | |
A compound that can inhibit glutathione S-transferase, possibly impacting glutathione-dependent processes associated with GSH-1. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
An agent that reacts with glutathione, which may reduce its availability for processes where GSH-1 is involved. | ||||||
Vitamin K3 | 58-27-5 | sc-205990B sc-205990 sc-205990A sc-205990C sc-205990D | 5 g 10 g 25 g 100 g 500 g | $26.00 $36.00 $47.00 $136.00 $455.00 | 3 | |
A compound that can deplete glutathione through redox cycling, potentially affecting GSH-1 functionality. | ||||||
Oltipraz | 64224-21-1 | sc-205777 sc-205777A | 500 mg 1 g | $286.00 $622.00 | ||
An agent known to modulate glutathione S-transferase levels, which could influence GSH-1 activity. | ||||||
Ethyl Acetate, HPLC | 141-78-6 | sc-360247 sc-360247A | 1 L 4 L | $122.00 $326.00 | ||
A specific inhibitor of glutathione peroxidase, which could impact redox balance and influence GSH-1. | ||||||
Acetaminophen | 103-90-2 | sc-203425 sc-203425A sc-203425B | 5 g 100 g 500 g | $41.00 $61.00 $194.00 | 11 | |
Overdose can deplete glutathione stores, affecting GSH-1 related pathways by reducing available glutathione. | ||||||
Nitrofurantoin | 67-20-9 | sc-212399 | 10 g | $84.00 | ||
A compound that under certain conditions can deplete glutathione, potentially impacting GSH-1 activity. | ||||||